Evolution of substance use, neurological and psychiatric symptoms in schizophrenia and substance use disorder patients: a 12-week, pilot, case-control trial with quetiapine

Evolution of substance use, neurological and psychiatric symptoms in schizophrenia and substance use disorder patients: a 12-week, pilot, case-control trial with quetiapine

Neurological and psychiatric symptoms are consequences of substance abuse in schizophrenia and non-schizophrenia patients. The present case-control study examined changes in substance abuse/dependence and neurological and psychiatric symptoms in substance abusers with (DD group, n=26) and without sc...

Full description

Bibliographic Details
Main Authors: Simon eZhornitsky, Emmanuel eStip, Joelle eDesfosses, Tania ePampoulova, Elie eRizkallah, Pierre-Paul eRompre, Lahcen Ait Bentaleb, Olivier eLipp, Jean-Pierre eChiasson, Alain eGendron, Stephane ePotvin
Format: Article
Language:English
Published: Frontiers Media S.A. 2011-05-01
Series:Frontiers in Psychiatry
Subjects:
Cannabis
Schizophrenia
psychosis
paranoia
parkinsonism
akathisia
Online Access:http://journal.frontiersin.org/Journal/10.3389/fpsyt.2011.00022/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fpsyt.2011.00022/full

Similar Items